Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by skys1


V.TLT

RE:RE:RE:RE:3/3 for the 6-month cystoscopy of low-dose patients ...

I have followed Roger for almost 4 years now. His current quiet behavior is...

October 11, 2017

V.TLT

RE:RE:RE:RE:Fourth Patient was treated with full dose on July 20th

Great post Macer. Thanks. 1433 will rank right up there with Insulin??? WOW!!...

August 24, 2017

V.TLT

Deals???

We already know 1433 kills human cancer cells. I think by now we know it...

May 14, 2017

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE: Sell Out

Agree Vestor. So far nothing is out of line on the meeting. It's being...

May 13, 2017

V.TLT

RE:RE:RE:RE:RE:Theralase meeting notice just posted to Sedar

My guess is that they already know the probable result of the treatment for...

May 9, 2017

V.TLT

RE:RE:RE:Langosta, we should expect inflamation

Vestor, to some investors $20 billion might seem outlandish, but one of the...

May 7, 2017

V.TLT

RE:RE:RE:Y don't u liberal 'SNOW FLAKES'

Vestor, We have several Canadian friends that winter here in Myrtle Beach SC....

May 5, 2017

V.TLT

RE:Tried to place a sell order at 1.62

opsd - In regards your question yesterday about getting a rejection on a sell...

March 3, 2017

V.TLT

RE:Tried to place a sell order at 1.62

opsd1, Yes that restriction is normal.

March 2, 2017

V.TLT

RE:RE:RE:TLD-1433 has high potentcy in 2 hard-to-beat indications

Phil ..., well said.

February 13, 2017

V.TLT

RE:RESPONSE

Thanks Fred, It appears we might have a 1b trial for brain cancer before this...

February 4, 2017

V.TLT

RE:RE:RE:RE:RE:RE:Trial halted on remarkable results. Replaced placebo by drug

Vestor: I'm from Northern New England where the soil is full of rounded...

January 16, 2017

V.TLT

RE:RE:RE:Sent e-mail to Al at KEReport this AM

TLT is an advertiser. That doesn't get it a weekly interview, with Al...

January 10, 2017

V.TLT

RE:Sent e-mail to Al at KEReport this AM

I'll do the same. Al used to have Roger on every week or two. It's...

January 10, 2017

V.TLT

RE:RE:RE:Bladder Cancer Canada blitzing since Dec. 21st

LaserrStock29, agree the logic for the question is solid. Only an egotistical...

December 29, 2016

V.TLT

RE:Bladder Cancer Canada blitzing since Dec. 21st

With such a rich potential patient source as Bladder Cancer Canada, why are...

December 29, 2016

V.TLT

AGM attendees

Well done, and thanks to the attendees of the AGM for their valuable reports....

December 12, 2016

V.TLT

RE:RE:I guess this was bad news..lol

br /> Agree. The share price reaction to all this is astounding. The only...

December 9, 2016

V.TLT

RE:KKK support Donald Trump

NONSENSE!!! How can Trump control anything the KKK or Duke says or does? He...

November 4, 2016

V.TLT

Stock price

Share price won't do much until TLT can get off the Venture. Roger said...

November 4, 2016

Featured Company